glp-1 drugs and alzheimer's Older drug may help protect brains of patients Could diabetes and weight loss
Description
doi: 10.3390/ma14154135

Also, Kolijin et al
:max_bytes(150000):strip_icc()/DiabetesMentalHealth2-73d13703a7c3442ca4fce0a2e71f15b0.jpg)
[DOI] [PubMed] [Google Scholar] 179

AE were similar between bimagrumab and placebo, although bimagrumab was associated with transiently elevated pancreatic and liver enzymes [97]

Market Size and Growth The market size for GLP-1 drugs (including diabetes and obesity indications) is already in the tens of billions of dollars annually

PMC (PubMed Central)
